ELI LILLY & Co Logo

ELI LILLY & Co

A research-based company that develops and sells pharmaceutical products.

LLY | US

Overview

Corporate Details

ISIN(s):
US5324571083
LEI:
Country:
United States of America
Address:
LILLY CORPORATE CTR, 46285 INDIANAPOLIS

Description

Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 22:00 English 7.8 KB
2025-11-26 22:00 English 10.6 KB
2025-11-25 22:00 English 7.9 KB
2025-11-24 22:00 English 9.0 KB
2025-11-24 21:01 English 8.6 KB
2025-11-21 22:19
8-K
English 84.6 KB
2025-11-21 22:00 English 7.9 KB
2025-11-20 22:00 English 7.9 KB
2025-11-19 22:00 English 8.3 KB
2025-11-19 21:05 English 8.5 KB
2025-11-18 22:39
FORM 4
English 6.8 KB
2025-11-18 22:26
FORM 4
English 7.3 KB
2025-11-18 22:25
FORM 4
English 6.7 KB
2025-11-18 22:23
FORM 4
English 7.1 KB
2025-11-18 22:21
FORM 4
English 6.6 KB

Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELI LILLY & Co

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.